Do you have the same question? Follow this Question
Jan 20, 2025 - 10:23 AM
We’ve provided several answers to questions related to Nexlizet (Bempedoic acid and Ezetimibe) , see some other helpful Q&A related to this product.
Question: What are the most common side effects of Nexlizet?
Answer:
Question: What is the risk associated with uric acid levels?
Answer: This medication can cause an increase in uric acid levels, leading to gout. Monitoring uric acid levels is important for patients with a history of gout or those at risk, ensuring they avoid potential complications.
Question: Can this medication be taken with food?
Answer: Yes, it can be taken with or without food. This flexibility in administration can improve patient compliance by allowing them to take the medication at their convenience.
Question: What is the contraindication regarding pregnancy?
Answer: This medication is contraindicated during pregnancy. This is crucial information for women of childbearing age as it highlights potential risks to fetal development.
Question: How is this medication administered?
Answer: This medication is administered by mouth. Oral administration is convenient and non-invasive, making it easier for patients to adhere to their treatment regimen.
Question: What is the elimination half-life of the product?
Answer: The elimination half-life of the product is 21±11 hours. This information helps in understanding how long the drug stays active in your system, which can affect dosing intervals and overall treatment plans.
View all Nexlizet (Bempedoic acid and Ezetimibe) Questions & Answers
